Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma

Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma

Introduction and aim. 5-Fluorouracil (5-FU) is the most commonly used chemotherapeutic drug in the treatment of cholangiocarcinoma (CCA). Since development of drug resistance to 5-FU in CCA patients is the primary cause of treatment failure, a better understanding of the mechanism of drug resistance...

Full description

Bibliographic Details
Main Authors: Sirinapa Sribenja, Nichapavee Natthasirikul, Kulthida Vaeteewoottacharn, Kanlayanee Sawanyawisuth, Chaisiri Wongkham, Patcharee Jearanaikoon, Sopit Wongkham
Format: Article
Language:English
Published: Elsevier 2016-07-01
Series:Annals of Hepatology
Subjects:
Tβ10
5-FU
Chemotherapeutic resistance
ATP-binding cassette transporters
Multidrug resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119311470

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119311470

Similar Items